ISRAR SIDDIQI: Open Payments
NPI 1346289501 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 51 payments from 17 companies in 2025. Trend: 2023 $1,105 · 2024 $1,237 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $128 |
| Axsome Therapeutics, Inc. | 6 | $127 |
| HARMONY BIOSCIENCES LLC | 5 | $119 |
| JAZZ PHARMACEUTICALS INC. | 4 | $99 |
| ABBVIE INC. | 5 | $98 |
| Viatris Specialty LLC | 4 | $91 |
| Verona Pharma, Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $71 |
| PFIZER INC. | 3 | $70 |
| Insulet Corporation | 2 | $55 |
Products named: AUSTEDO XR, WAKIX, XYWAV, VRAYLAR, Sunosi, YUPELRI, Ohtuvayre, ELIQUIS.
Industry payments across IN — which companies pay providers there.
